Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 11 - 07 symbols : Lly save search
Lilly to begin rollout of Tempo® Personalized Diabetes Management Platform
Published: 2022-11-07 (Crawled : 17:00) - prnewswire.com
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: 0.17%
H: 2.51%
C: 1.97%
DXCM | $136.51 1.45% 1.43% 3M
|
Health Technology
|
| O: 0.92%
H: 0.6%
C: -0.53%
tempo management diabetes platform
Florida's Life Science Leaders United to Celebrate 25 Years of Innovation and Growth in the State
Published: 2022-11-07 (Crawled : 15:00) - prnewswire.com
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: 0.17%
H: 2.51%
C: 1.97%
BSX | $68.12 1.01% 0.02% 6.6M
|
Health Technology
|
| O: 0.57%
H: 0.98%
C: 0.32%
life state innovation growth
Global Osteoporosis Drugs Market Report 2022: Anabolic Drug Developments Show High Potential to Reshape Sector
Published: 2022-11-07 (Crawled : 12:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -3.13%
H: 0.0%
C: 0.0%
GSK | $39.95 -1.36% 0.0% 2.4M
|
Health Technology
|
| O: -3.09%
H: 0.72%
C: -0.09%
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: 0.17%
H: 2.51%
C: 1.97%
AMGN | $265.64 0.05% 0.05% 2M
|
Health Technology
|
| O: -0.33%
H: 3.48%
C: 3.31%
drug global report potential market osteoporosis
Insulin Market is Likely to Upsurge USD 25.12 Billion Globally by 2029, Size, Share, Trends, Demand, Market Dynamics, Growth Forecast and Challenges
Published: 2022-11-07 (Crawled : 10:00) - prnewswire.com
SNYNF | $92.966 -2.18% 630
|
Health Technology
|
| O: -2.01%
H: 0.88%
C: 0.88%
NVO | $123.45 -0.36% 0.03% 3M
|
Health Technology
|
| O: 0.91%
H: 1.82%
C: 1.43%
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: 0.17%
H: 2.51%
C: 1.97%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: -0.46%
H: 0.0%
C: 0.0%
insulin growth market
Innovent Releases Results of a Phase 3 Clinical Study of Tafolecimab（IBI306）in Chinese Patients with non- Familial Hypercholesterolemia at the American Heart Association (AHA) Scirntific Sessions 2022
Published: 2022-11-07 (Crawled : 01:00) - prnewswire.com
SNYNF | $92.966 -2.18% 630
|
Health Technology
|
| O: -2.01%
H: 0.88%
C: 0.88%
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: 0.17%
H: 2.51%
C: 1.97%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: -0.46%
H: 0.0%
C: 0.0%
INCY | $53.23 -0.37% -0.38% 1.5M
|
Health Technology
|
| O: 0.25%
H: 0.46%
C: -2.05%
ibi306 sessions chinese heart results study hypercholesterolemia
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
WISA 4 | $6.06 246.29% 71.12% 200M
|
Electronic Technology
VIAO | $0.265 -13.96% 35.85% 960K
|
Electronic Technology
JAGX | $0.178 49.83% 33.26% 600M
|
Health Technology
SXTC | $1.68 43.59% 30.36% 34M
|
Health Technology
DYNT | $0.531 43.36% 30.24% 22M
|
Health Technology
KA | $0.4796 41.06% 29.11% 5.3M
|
Manufacturing
PALI | $5.86 40.87% 29.01% 29M
|
Manufacturing
CLNN | $0.319 -3.74% 28.75% 6.3M
|
BSGM | $1.52 38.18% 27.63% 3.3M
|
Health Technology
MCBC | $13.67 37.66% 27.36% 2.2M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.